Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,205,075
-
Share change
-
-360,156
-
Total reported value
-
$7,627,698
-
Price per share
-
$6.33
-
Number of holders
-
40
-
Value change
-
-$2,433,916
-
Number of buys
-
25
-
Number of sells
-
28
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2024
As of 30 Jun 2024,
Nuvectis Pharma, Inc. - COM (NVCT) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,205,075 shares.
The largest 10 holders included
VANGUARD GROUP INC, BALDWIN BROTHERS LLC/MA, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, and FORBES J M & CO LLP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.